Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1.
William J
WJ
Groh
D000889:Anti-Arrhythmia Agents / Q000009:adverse effects*; D000075202:Contraindications; D006801:Humans; D008801:Mexiletine / Q000009:adverse effects*; D009223:Myotonic Dystrophy / Q000188:drug therapy / Q000503:physiopathology; D026941:Sodium Channel Blockers / Q000009:adverse effects*
D000889:Anti-Arrhythmia Agents; D026941:Sodium Channel Blockers; D008801:Mexiletine